Lawsuit for Investors who Lost over $100,000 in shares of Aehr Test Systems, Inc. (NASDAQ: AEHR) between January and March 2024 announced by Shareholders Foundation

Core Viewpoint - Aehr Test Systems, Inc. has faced significant revenue forecast reductions due to delays in customer orders, leading to a lawsuit from investors alleging misleading statements regarding the company's financial health [3][4][5]. Financial Guidance and Forecasts - In October 2023, Aehr Test Systems projected total revenue for fiscal year 2024 to be at least $100 million, indicating over 50% year-over-year growth [3]. - On January 9, 2024, the company revised its revenue forecast down to $75-$85 million, attributing this to delays in new orders from customers [3]. - Following this, on March 25, 2024, Aehr announced preliminary Q3 2024 revenue of approximately $7.6 million, significantly below the consensus estimate of $14.32 million, and further reduced its 2024 revenue forecast to at least $65 million [4]. Legal Actions - A lawsuit was filed on December 3, 2024, by an investor alleging that Aehr Test Systems made false or misleading statements regarding its order delays and the impact on revenue growth, claiming that the company's public statements were materially false and misleading [5]. - Investors who purchased more than $100,000 in shares between January 9, 2024, and March 24, 2024, have options to pursue legal action, with a deadline set for February 3, 2025 [2].